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Abstract. Machine learning is a powerful paradigm within which to
analyze 1H-MRS spectral data for the automated classification of tumor
pathologies aimed to facilitate clinical diagnosis. The high dimensional-
ity of the involved data sets makes the discover of computational models
a challenging task. In this study we apply a feature selection algorithm
in order to reduce the complexity of the problem. The obtained experi-
mental results yield a remarkable classification performance of the final
induced models, both in terms of prediction accuracy and number of in-
volved spectral frequencies. A dimensionality reduction technique that
preserves the class discrimination capabilities is used for the visualization
of the final selected frequencies, thus enhancing their interpretability.
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1 Introduction
Proton Magnetic Resonance Spectroscopy (1H-MRS) is a powerful technique
that helps to observe metabolic processes in living tissue [1]. Although these
metabolic functions are not fully understood, it is possible to employ machine
learning (ML) techniques on this kind of data for the diagnosis and grading of
adult brain tumors [2]. Several recent examples in the literature use ML tech-
niques for distinguishing between different brain tumor pathologies (e.g. [3], [4]).
Due to the high dimensionality (nearly 390 spectral points in this study), many
efforts have used dimensionality reduction methods (mainly feature extraction)
to lower the complexity of the problem. Methods such as Principal Components
Analysis (PCA) have recognized drawbacks that limit their applicability in this
problem: the result is difficult to interpret in original terms and PCA it is not
designed to preserve class separability. In the present study we are interested in
performing a feature selection study in two types of 1H-MRS spectral data by
constructing an ad hoc combination of both. We use a simple filter technique for
feature selection as a fast method to generate relevant subsets of spectral fre-
quencies, complemented by the use of bootstrapping techniques. In this paper, we
report experimental results that support the practical advantage of combining
robust feature selection and classification techniques in this application field.
2 An entropic filtering algorithm
Mutual Information (MI) measures the mutual dependence of two random vari-
ables. It has been used with success as a criterion for feature selection in machine
learning tasks. In this work we use this concept embedded in a fast algorithm
that computes MI between a set of variables and the class variable by generating
first a “super-feature”, obtained considering the concatenation of each combina-
tion of possible values of its forming features. In symbols, let X = {X1, ..., Xn}
be the original feature set and consider a subset τ = {τ1, · · · , τk}. A single fea-
ture Vτ can be obtained uniquely, whose possible values are the concatenations
of all possible values of the features in τ . The conditional entropy between Vτ
and the class feature Y is then:
H(Y |τ1, · · · , τk) = H(Y |Vτ ) = −
∑
v∈Vτ
∑
y∈Y
p(v, y) log
p(v, y)
p(y)
. (1)
Proceeding in this way, the MI can be determined as a simple bivariate case:
I(Vτ ;Y ) = H(Y )−H(Y |Vτ ). An index of relevance of the feature Xi ∈ X to a
class Y with respect to a subset τ ⊂ X, inspired on [5], is given by:
R(Xi;Y |τ) = I(Xi;Y |Vτ )
H(Y |Vτ ) =
H(Y |Vτ )−H(Y |Xi;Vτ )
H(Y |Vτ ) . (2)
This index of relevance of a feature subset is to be maximized (it has a maximum
value of 1). This measure is used in this study to evaluate subsets of spectral
frequencies, embedded into a filter forward-selection strategy, conforming the
Entropic Filtering Algorithm (EFA). A detailed description and a fast imple-
mentation of the whole algorithm can be found in [reference removed due to
blind evaluation]
3 Experimental setup
The echo time is an influential parameter in 1H-MRS spectra acquisition. In
short-echo time (SET) spectra (typically 20-40 ms) some metabolites are better
evaluated (e.g. lipids, myo-inositol, glutamine and glutamate). However, there
may be numerous overlapping resonances (e.g. glutamate/glutamine at 2.2 ppm
and NAA at 2.01 ppm) which make the spectra difficult to interpret [6]. A long-
echo time or LET (270-288 ms) yields less metabolites but also less baseline
distortion, resulting in a more readable spectrum. There are a few studies com-
paring the classification potential of the two types of spectra (see e.g. [6], [7]).
These works seem to give a slight advantage to using SET information or else
suggest a combination of both types of spectra, which is the possibility explored
in this work. The analyzed 1H-MRS data sets are detailed as follows:
– 195 single voxel long-echo time LET spectra acquired in vivo from brain tu-
mor patients, including: meningiomas (55 cases), glioblastomas (78), metas-
tases (31), astrocytomas Grade II (20), oligoastrocytomas Grade II (6) and
oligodendrogliomas Grade II (5);
– 217 single voxel short-echo time SET spectra: meningiomas (58 cases), metas-
tases (38), glioblastomas (86), astrocytomas Grade II (22), oligoastrocy-
tomas Grade II (6) and oligodendrogliomas Grade II (7).
– 195 single voxel long/short-echo time LSET spectra, obtained by merging
the 195 common observations of the two previous data sets.
The merged LSET spectra were bundled into four pathology groupings (super-
classes): Normal tissue (normal brain tissue white matter or brain abscesses),
High-grade malignant tumors (metastases and glioblastomas), Low-grade ma-
lignant gliomas (astrocytomas, oligodendrogliomas and oligoastrocytomas) and
Others (the rest of tumors). The spectra consist of 390 frequency intensity values,
from 4.21 ppm down to 0.51 ppm. Three different experiments were designed in
order to test the capability of the proposed techniques in distinguishing normal
vs. tumorous tissue: 1-Normal tissue vs. high-grade malignant tumors –named
EXP1–, 2-Normal tissue vs. low-grade malignant tumors –named EXP2– and
3-Normal tissue vs. Others –named EXP3– generating three data sets (LSET1,
LSET2 and LSET3), one for each experiment.
To obtain more reliable relevant features we advocate for the use of bootstrap
resampling in the feature selection process. This technique is here used to yield
mean performance estimates and their variability, and thus a more reliable mea-
sure of predictive ability; these methods are also well-suited when sample size is
small or the distribution of the statistic is unknown. The three data sets LSET1
to LSET3 were used to generate 1,000 bootstrap samples for each experiment.
First, the EFA is applied to the bootstrap samples to obtain a Best Spectral
Subset for each experiment (named BSS1 to BSS3). Notice that each relevance
value calculated in the EFA is the average across the bootstrap samples, to guide
and stabilize the algorithm. Second, the classifier development stage is conducted
using the original datasets (LSET1 to LSET3) with the obtained BSSs. Five clas-
sifiers were evaluated by means of 10 times 10-fold Cross Validation (10x10cv):
a nearest-neighbor (kNN) with parameter k (number of neighbors), the Na¨ıve
Bayes classifier (NBC), a Linear Discriminant classifier (LDC), Support Vector
Machine with linear kernel (lSVM) and parameter C (regularization constant)
and Support Vector Machine with radial kernel (rSVM) and parameters C and
σ2 (amount of smoothing in the kernel). The parameters are optimized via a
grid search process using 10x10cv.
4 Experimental results
The obtained BSSs are detailed in Table 2 and plot in Fig. 1 against average
spectra per super-class. All three (BSS1, BSS2 and BSS3) deliver maximum
relevance (R = 1) with as little as 25, 7 and 16 spectral frequencies, respectively.
It is observed that LET frequencies are preferred over SET frequencies; selected
spectral points are specially located in the Choline/Creatine (3.32 ppm to 3.01
ppm), Glutamate/Glutamine (2.71 ppm to 2.41 ppm), N-acetylaspartate (2.10
ppm to 1.80 ppm) and Lipids (around 1.19 ppm) peaks.
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Fig. 1. Spectral subsets found by the EFA that reach maximum relevance (R = 1) as positioned in
the whole spectrum. The resonance frequency position of each peak on the plot is dependent on the
chemical environment of the nucleus and is usually expressed as parts per million or ppm.
Experiment NBC kNN LDC lSVM rSVM
EXP1 92.81±0.005 95.32±0.002 94.47±0.04 96.45±0.004 96.62±0.004
EXP2 95.05±0.007 98.19±0.000 95.22±0.006 98.00±0.003 98.37±0.002
EXP3 92.68±0.006 95.33±0.005 91.11±0.006 94.21±0.007 94.22±0.005
Table 1. 10x10cv accuracies (in %) and standard errors per experiment and classifier using the
selected subsets of spectral points BSS1 to BSS3 –see Fig. 1. Best results are marked in bold.
Experiment Best Spectral Subset BSS
EXP1 L2.04, L2.01, L1.99, L1.19, L2.43, L1.95, L0.94, L1.93, L1.21, L1.91, L2.56
L1.13, L1.23, L3.03, L2.58, L1.34, L1.38, L3.17, L3.95, L3.22, L3.93, L2.39
L3.32, S1.02, L3.00
EXP2 L3.22, L3.24, L2.04, L1.99, L2.69, L3.26, L1.27
EXP3 L3.19, L3.20, L2.04, L2.01, L1.99, L3.24, L1.97, L2.44, L2.63, L2.56, L2.65
L1.93, L1.91, L1.89, L2.48, L1.02
Table 2. Spectral subsets found by the EFA that reach maximum relevance (R = 1). The prefix (L
or S) indicates LET or SET origin.
Classification stage results in Table 4 show remarkable values, specially when
using the rSVM. Confidence intervals (CI) for these results (at the 95% level)
are: (95.91-97.73) for the rSVM (EXP1), (98.01-98.73) for the rSVM (EXP2) and
(94.31, 96.35) for kNN (EXP3). Note that the CIs are about 1% to 2% wide,
a relatively low value, signaling a consistently stable generalization ability. A
Wilcoxon signed rank test is carried out as a way to asses significant differences
between the best result and all other classifiers, for each experiment –Table 4.
Moreover, in order to ascertain which super-classes are the most difficult to
separate, the full confusion matrices of the three experiments are shown in Table
3. It can be seen how average prediction is very accurate. However, there remain
some data observations (one, or two at the most) that are wrongly predicted as
non-tumorous when in fact they are, which is serious. These observations should
receive special attention by an oncologist to check whether they are correct.
In a medical context, data visualization in a low-dimensional representation
space may become extremely important, helping radiologists to gain insights into
what undoubtedly is a complex domain. We use in this work a method based on
the decomposition of the data scatter matrix, with the property of maximizing
True EXP1 (rSVM)
Class NO HG
NO 6.37±0.18 1.30±0.18
HG 0.02±0.07 36.13±0.09
True EXP2 (kNN)
Class NO LG
NO 10.03±0.10 0.03±0.08
LG 0.00±0.00 7.67±0.09
True EXP3 (rSVM)
Class NO OT
NO 7.07±0.19 0.60±0.17
OT 0.50±0.20 15.50±0.20
Table 3. 10x10cv average confusion matrices (using the rSVM on EXP1 and EXP2 and kNN on
EXP3). These results correspond to the highest accuracy values (Table 4) in each experiment. True
class falls vertically. Super-classes are as follows: NO is Normal tissue, HG are High-grade tumors,
LG are Low-grade tumors and OT are Others.
Test p < 0.05
rSVM vs. NBC 0.002
rSVM vs. kNN 0.020
rSVM vs. LDC 0.002
rSVM vs. lSVM 0.438
Test p < 0.05
rSVM vs. NBC 0.004
rSVM vs. kNN 1.000
rSVM vs. LDC 0.002
rSVM vs. lSVM 0.049
Test p < 0.05
kNN vs. NBC 0.004
kNN vs. LDC 0.002
kNN vs. lSVM 0.234
kNN vs. rSVM 0.012
Table 4. Wilcoxon signed rank test p-values in each experiment. Values lower than 0.05 signal
significant differences at the 95% level.
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Fig. 2. Projection of the data sets (using the selected BSS) onto the first two eigenvectors of the
scatter matrices as coordinate system. Left: EXP1, center: EXP2, right: EXP3. Circles represent
normal tissue gliomas; filled squares represent tumorous samples (left: high-grade malignant tumors,
center: low-grade malignant tumors and right: other tumors).
the separation between the projections of compact groups of data (tumor classes,
in this work). This is a recently introduced method that leads onto the definition
of low-dimensional projective spaces with good separation between classes, even
when the data covariance matrix is singular; further details about this method
can be found in [8]. The visualizations of our best results (again those boldfaced
in Table 4) show a clear separation between super-classes, being this latter result
highly coincident with the reported 10x10cv accuracy values (95-98%) reached
by the developed classifiers, despite the differences in dimension –Fig. 2, a fact
that adds support to the consistency and clinical value of the results.
5 Conclusions and future work
1H-MRS is yet to become a standard method for day-to-day clinical diagnosis
of brain tumors, despite being a non-invasive technique. In this study, we report
experimental results that support the practical advantage of combining robust
feature selection and classification techniques in this application field. An at-
tractive accurate classification is obtained with parsimonious and interpretable
subsets of spectral frequencies. A dimensionality reduction technique that pro-
vides a data projection –while preserving the class discrimination achieved by a
classifier– is also used in our study. The feature filter algorithm has advantage
in being simple to implement and requiring no parameter tuning. The reported
results also signal a few troublesome data observations that shall deserve clini-
cal attention. Future research will extend the use of the proposed methodology
to the analysis of other brain tumor classification problems involving different
pathologies and pathology groupings.
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